Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-09-023632
Filing Date
2009-08-04
Accepted
2009-08-07 16:47:19
Documents
1
Effectiveness Date
2009-08-04

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-09-023632.paper CERTNAS 294
  Scanned paper document scanned.pdf   38773
  Complete submission text file 9999999997-09-023632.txt   1686
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CERTNAS | Act: 34 | File No.: 001-33637 | Film No.: 09037009
SIC: 2834 Pharmaceutical Preparations